SCHEMBL2637590

SCHEMBL2637590

O=c1[nH]n2c(=O)cc(-c3ccc(Cl)cc3)[nH]c2c1Nc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
KMT2A Q03164 4/20 0.41
PDE10A Q9Y233 1/20 0.41
GSK3B P49841 1/20 0.40
MET P08581 2/20 0.40
KDR P35968 2/20 0.40
ALDH1A1 P00352 5/20 0.38
HPGD P15428 4/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
GAA P10253 1/20 0.38
LMNA P02545 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PARP1 P09874 1/20 0.36
CXCR2 P25025 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637594 0.91 MAT2A (0.37) KDM4EKMT2AGSK3BMETKDR
SCHEMBL2637722 0.88 PSD (0.39) KDM4EKMT2APDE10AALDH1A1HPGD
SCHEMBL2637972 0.88 MEN1 (0.41) KDM4EKMT2AGSK3BALDH1A1HPGD
SCHEMBL2637584 0.88 MET (0.39) KDM4EKMT2AMETKDRALDH1A1
SCHEMBL2637170 0.83 MAPT (0.43) KDM4EKMT2AALDH1A1HPGDGAA
SCHEMBL2637556 0.82 POLB (0.46) KDM4EKMT2AMETKDRALDH1A1
SCHEMBL2638843 0.79 MAPT (0.35) KDM4EKMT2AALDH1A1HPGDGAA
SCHEMBL2637795 0.79 MEN1 (0.44) KDM4EKMT2AGSK3BALDH1A1HPGD
SCHEMBL2637724 0.77 TYMP (0.35) KDM4EKMT2AMETKDRALDH1A1
SCHEMBL2637595 0.76 MAPT (0.43) KMT2AGAALMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed